Efficacy of psychosocial interventions on psychological outcomes among people with cardiovascular diseases: a systematic review and meta-analysis

Klainin‐Yobas, Piyanee; Ng, Shu Huey; Stephen, Pricilia Dew Maria; Lau, Ying

doi:10.1016/j.pec.2015.10.020

Cited by 37 publications

(25 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In support of this possibility, studies have shown that antidepressant treatment reduces mortality of individuals with depression and heart disease (107,108). For individuals who cannot or do not want to take pharmacotherapies for depression, nonpharmacologic treatments such as talk therapy and stress management have been shown to be effective (109). Taken together, our results reinforce the notion that in addition to treating cardiovascular symptoms, clinicians should assess the presence of mood disorder and treat both conditions to improve their patients' quality of life.…”

Section: Discussionmentioning

confidence: 99%

Pathogenesis of depression‐ and anxiety‐like behavior in an animal model of hypertrophic cardiomyopathy

et al. 2017

View full text Add to dashboard Cite

Cardiovascular dysfunction is highly comorbid with mood disorders, such as anxiety and depression. However, the mechanisms linking cardiovascular dysfunction with the core behavioral features of mood disorder remain poorly understood. In this study, we used mice bearing a knock-in sarcomeric mutation, which is exhibited in human hypertrophic cardiomyopathy (HCM), to investigate the influence of HCM over the development of anxiety and depression. We employed behavioral, MRI, and biochemical techniques in young (3-4 mo) and aged adult (7-8 mo) female mice to examine the effects of HCM on the development of anxiety- and depression-like behaviors. We focused on females because in both humans and rodents, they experience a 2-fold increase in mood disorder prevalence males. Our results showed that young and aged HCM mice displayed echocardiographic characteristics of the heart disease condition, yet only aged HCM females displayed anxiety- and depression-like behaviors. Electrocardiographic parameters of sympathetic nervous system activation were increased in aged HCM females controls and correlated with mood disorder-related symptoms. In addition, when compared with controls, aged HCM females exhibited adrenal gland hypertrophy, reduced volume in mood-related brain regions, and reduced hippocampal signaling proteins, such as brain-derived neurotrophic factor and its downstream targets controls. In conclusion, prolonged systemic HCM stress can lead to development of mood disorders, possibly through inducing structural and functional brain changes, and thus, mood disorders in patients with heart disease should not be considered solely a psychologic or situational condition.-Dossat, A. M., Sanchez-Gonzalez, M. A., Koutnik, A. P., Leitner, S., Ruiz, E. L., Griffin, B., Rosenberg, J. T., Grant, S. C., Fincham, F. D., Pinto, J. R. Kabbaj, M. Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy.

show abstract

Section: Discussionmentioning

confidence: 99%

Pathogenesis of depression‐ and anxiety‐like behavior in an animal model of hypertrophic cardiomyopathy

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Recent research suggests that the management of GI disease can be improved by reducing stress with support from psychological interventions, which in turn improves health‐related quality of life (HRQoL) and medication adherence . Psychotherapy has been used with good effects in chronic diseases and has shown promise in patients with GI diseases …”

Section: Introductionmentioning

confidence: 99%

“…6,7 Recent research suggests that the management of GI disease can be improved by reducing stress with support from psychological interventions, which in turn improves health-related quality of life (HRQoL) and medication adherence. 8,9 Psychotherapy has been used with good effects in chronic diseases [10][11][12] and has shown promise in patients with GI diseases. 13 The widespread use of psychotherapy is limited for GI conditions, and one of the reasons suggested for this is the limited psychological resources available in these populations.…”

Section: Introductionmentioning

confidence: 99%

Systematic review with meta‐analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease

Hanlon

Hewitt

Bell

et al. 2018

Aliment Pharmacol Ther

View full text Add to dashboard Cite

show abstract

“…Lessons learned from beneficial effects of psychoeducation on patients' stress and anxiety levels have led to the implementation of psychoeducation in the treatment regimens for patients with cardiovascular diseases, where psychosocial programs with psychoeducation and stress management help to reduce anxiety [17]. It has also been recommended that psychoeducation becomes a standard of care in pediatric oncology [18].…”

Section: What Is Psychoeducation and Where Does It Help?mentioning

confidence: 99%

Psychoeducation as an Opportunity for Patients, Psychiatrists, and Psychiatric Educators: Why Do We Ignore It?

et al. 2017

View full text Add to dashboard Cite

Providing information and educating patients about their illness and options for treatment is an essential part of medical practice. Little is known about medical students' and residents' training in these skills, however. It is well known that cooperation, effective communication, and a good relationship between the psychiatrist, the patient, and the patient's family improve the prognosis of severe mental illness. If the patient and family members are expected to become competent partners and to cooperate in long-term treatment, psychiatrists have to share information about the illness and its treatment with them. As providers of care, psychiatrists obviously have the knowledge and experience that patients and their families do not. The only way to bridge this natural knowledge gap is to share the information in a comprehensible and structured way, in what is known today as psychoeducation. What Is Psychoeducation and Where Does It Help?Psychoeducation is the provision of systematic, relevant, broad, and up-to-date information about an illness or condition, including its diagnosis and treatment. Psychoeducational programs provide both disease-specific information, e.g., early recognition and management of relapse symptoms or any potential genetic implications of the illness and general information, e.g., promotion of healthy lifestyle, problem-solving and communication skills training, identification of stressors in households, and education of family members and primary care takers in their amelioration. Furthermore, psychoeducation includes information on how to explain aspects of living with an illness to family members so that they can understand the effect of the illness and assist the patient and treatment providers in the treatment program.There is evidence that psychoeducation improves the outcomes of mental illness and many other medical illnesses. Family interventions, including psychoeducation for schizophrenia, have proved to be one of the most consistently effective treatment modalities available, with relapse rate reduction at 50-60% over treatment as usual [1,2]. Besides relapse severity reduction, psychoeducation leads to less frequent relapses, better treatment adherence, lower self-stigma, better quality of life, improvement of social competencies, active engagement in rehabilitation, and lower cost of care, either alone or as a part of complex treatment regimen [3][4][5][6][7]. Thus, family psychoeducation is recommended in several schizophrenia treatment guidelines [8][9][10], for example, as an evidence-based intervention.There is similar evidence that psychoeducation and family interventions may reduce the recurrence of bipolar disorders and depression. Psychoeducation and cognitive behavioral therapy are associated with increased time to mood episode relapse or recurrence [11,12]. Preliminary evidence shows that family psychoeducation for patients with depressive disorders improves patient functioning and the well-being of family caregivers [13]. Similarly, psychoeducation seems to reduce...

show abstract

Efficacy of psychosocial interventions on psychological outcomes among people with cardiovascular diseases: a systematic review and meta-analysis

Cited by 37 publications

References 50 publications

Pathogenesis of depression‐ and anxiety‐like behavior in an animal model of hypertrophic cardiomyopathy

Pathogenesis of depression‐ and anxiety‐like behavior in an animal model of hypertrophic cardiomyopathy

Systematic review with meta‐analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease

Psychoeducation as an Opportunity for Patients, Psychiatrists, and Psychiatric Educators: Why Do We Ignore It?

Contact Info

Product

Resources

About